Lo Ann C. Peterson

Chronic lymphoproliterative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics

Robert W. McKenna, Janet L. Parkin, John H. Kersey et al. · The American Journal of Medicine · 1977 · 196 citations

Lymphoid Neoplasia, Surgical Pathology, Histopathology +6

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

Martin S. Tallman, David Hakimian, Kenneth J. Kopecky et al. · PubMed · 1999 · 83 citations

Hematological Malignancy, Bone Marrow Failure, Health Sciences +15

Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.

H Enright, Daniel Weisdorf, Lo Ann C. Peterson et al. · PubMed · 1992 · 33 citations

Pan B‐cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL)

Sara A. Monaghan, Lo Ann C. Peterson, Cathy James et al. · Cytometry Part B Clinical Cytometry · 2003 · 31 citations · Full text

Secondary Acute Myelogenous Leukemia with MLL Gene Rearrangement Following Radioimmunotherapy (RAIT) for Non-Hodgkin's Lymphoma

Chadi Nabhan, Lo Ann C. Peterson, Sara A. Kent et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2002 · 15 citations